These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 728711)

  • 81. Proceedings: Aspirin-induced hepatotoxicity in patients with RA or systemic lupus erythematosus (SLE).
    Seaman WE; Plotz PH; Ishak KG
    Arthritis Rheum; 1974; 17(3):325. PubMed ID: 4825655
    [No Abstract]   [Full Text] [Related]  

  • 82. Aspirin hepatotoxicity.
    Kanada SA; Kolling WM; Hindin BI
    Am J Hosp Pharm; 1978 Mar; 35(3):330-6. PubMed ID: 305202
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Letter: Aspirin hepatotoxicity.
    Hilton AM; Dymock IW
    Ann Intern Med; 1974 Aug; 81(2):271-2. PubMed ID: 4846112
    [No Abstract]   [Full Text] [Related]  

  • 84. Serum transaminases during salicylate therapy.
    Russell AS; Sturge RA; Smith MA
    Br Med J; 1971 May; 2(5759):428-9. PubMed ID: 5576002
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Aspirin hepatitis.
    Wolfe JD; Metzger AL; Goldstein RC
    Ann Intern Med; 1974 Jan; 80(1):74-6. PubMed ID: 4810352
    [No Abstract]   [Full Text] [Related]  

  • 86. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.
    Seaman WE; Ishak KG; Plotz PH
    Ann Intern Med; 1974 Jan; 80(1):1-8. PubMed ID: 4810348
    [No Abstract]   [Full Text] [Related]  

  • 87. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.
    Rich RR; Johnson JS
    Arthritis Rheum; 1973; 16(1):1-9. PubMed ID: 4692157
    [No Abstract]   [Full Text] [Related]  

  • 88. Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers.
    Seaman WE; Plotz PH
    Arthritis Rheum; 1976; 19(2):155-60. PubMed ID: 1259798
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Histopathologic manifestations of drug-induced hepatotoxicity.
    Zhang X; Ouyang J; Thung SN
    Clin Liver Dis; 2013 Nov; 17(4):547-64, vii-viii. PubMed ID: 24099017
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence?
    Travers RL; Hughes GR
    Br Med J; 1978 Dec; 2(6151):1532-3. PubMed ID: 728711
    [No Abstract]   [Full Text] [Related]  

  • 91. Aspirin, liver, and rheumatic diseases.
    Halla JT
    J Med Assoc State Ala; 1976 Sep; 46(3):23-5. PubMed ID: 789798
    [No Abstract]   [Full Text] [Related]  

  • 92. The treatment of SLE: the case of conservative management.
    Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):299-313. PubMed ID: 6214364
    [No Abstract]   [Full Text] [Related]  

  • 93. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
    Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
    Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rheumatologic disease and the liver.
    Schlenker C; Halterman T; Kowdley KV
    Clin Liver Dis; 2011 Feb; 15(1):153-64. PubMed ID: 21111998
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.